Monday, November 8, 2021
12–1 p.m.
Virtual via Zoom
Dr. Shenda Baker is an experienced entrepreneur and scientist in biopolymer interfaces, macromolecular and surface chemistry and nanostructured materials. She is the co-founder, president and CEO of , a company using glycopolymers to control infection, regeneration and inflammation at mucosal surfaces. While serving as the CEO for Synspira, she brought the first Synedgen licensed technology into clinical trials for inhaled treatment for patients with cystic fibrosis.